Tingting Huang
1095 Jiefang Avenue
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer.
Journal: Oncology research and treatment
Published: June 14, 2022
Upregulation of THBS1 is Related to Immunity and Chemotherapy Resistance in Gastric Cancer.
Journal: International journal of general medicine
Published: July 13, 2021
Apatinib exhibits synergistic effect with pyrotinib and reverses acquired pyrotinib resistance in HER2-positive gastric cancer via stem cell factor/c-kit signaling and its downstream pathways.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: May 17, 2020
Pyrotinib enhances the radiosensitivity of HER2‑overexpressing gastric and breast cancer cells.
Journal: Oncology reports
Published: March 08, 2020
AFP-producing hepatoid adenocarcinoma (HAC) of peritoneum and omentum: a case report and literature review.
Journal: OncoTargets and therapy
Published: May 21, 2019
FGFR2 Promotes Expression of PD-L1 in Colorectal Cancer via the JAK/STAT3 Signaling Pathway.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 29, 2018
FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: February 28, 2018
FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1.
Journal: International journal of oncology
Published: December 04, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026